135 related articles for article (PubMed ID: 37675165)
21. Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Wu J; Zhang Y; Ding T; Cheng R; Gong W; Guo Y; Luo Y; Pan Y; Zhai Q; Sun W; Lin D; Sun B
Endocr Pathol; 2020 Mar; 31(1):39-45. PubMed ID: 31788765
[TBL] [Abstract][Full Text] [Related]
22. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
Ng WK; Chow JC; Ng PK
Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
[TBL] [Abstract][Full Text] [Related]
23. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
Tsao SC; Su YC; Wang SL; Chai CY
Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
[TBL] [Abstract][Full Text] [Related]
24. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
Chang YL; Lee YC; Liao WY; Wu CT
Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379
[TBL] [Abstract][Full Text] [Related]
25. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
26. [Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study].
Dessy E; Falleni M; Del Curto B; Braidotti P; Pietra GG
Pathologica; 2000 Dec; 92(6):496-502. PubMed ID: 11234300
[TBL] [Abstract][Full Text] [Related]
27. GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors.
Wang LJ; Greaves WO; Sabo E; Noble L; Tavares R; Ng T; DeLellis RA; Resnick MB
Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):505-11. PubMed ID: 19620839
[TBL] [Abstract][Full Text] [Related]
28. Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma.
Khoor A; Whitsett JA; Stahlman MT; Olson SJ; Cagle PT
Hum Pathol; 1999 Jun; 30(6):695-700. PubMed ID: 10374779
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
Ji N; Lee Y; Lee SH; Kim HS
Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
[TBL] [Abstract][Full Text] [Related]
30. Rapid Immunohistochemistry With Thyroid Transcription Factor-1 for Pulmonary Adenocarcinoma.
Konno H; Saito H; Nanjo H; Hiroshima Y; Kurihara N; Fujishima S; Atari M; Sato Y; Motoyama S; Nakamura R; Akagami Y; Minamiya Y
Ann Thorac Surg; 2017 Aug; 104(2):471-476. PubMed ID: 28527968
[TBL] [Abstract][Full Text] [Related]
31. Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
El Hag M; Schmidt L; Roh M; Michael CW
Diagn Cytopathol; 2016 Apr; 44(4):299-304. PubMed ID: 26799356
[TBL] [Abstract][Full Text] [Related]
32. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
[TBL] [Abstract][Full Text] [Related]
33. Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker?
La Salvia A; Siciliani A; Rinzivillo M; Verrico M; Baldelli R; Puliani G; Modica R; Zanata I; Persano I; Fanciulli G; Bassi M; Mancini M; Bellino S; Giannetta E; Ibrahim M; Panzuto F; Brizzi MP; Faggiano A
Endocrine; 2024 Feb; 83(2):519-526. PubMed ID: 37775725
[TBL] [Abstract][Full Text] [Related]
34. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma.
Ordóñez NG
Am J Surg Pathol; 2000 Apr; 24(4):598-606. PubMed ID: 10757409
[TBL] [Abstract][Full Text] [Related]
35. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
Zamecnik J; Kodet R
Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
[TBL] [Abstract][Full Text] [Related]
36. Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.
Kim MY; Go H; Koh J; Lee K; Min HS; Kim MA; Jeon YK; Lee HS; Moon KC; Park SY; Kim WH; Chung DH
Histopathology; 2014 Aug; 65(2):195-206. PubMed ID: 24479710
[TBL] [Abstract][Full Text] [Related]
37. Transcription expression and clinical significance of TTF-1 mRNA in pleural effusion of patients with lung cancer.
Jiang B; Wu GP; Zhao YJ; Wang SC
Diagn Cytopathol; 2008 Dec; 36(12):849-54. PubMed ID: 18855882
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.
Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Mattsson JSM; Botling J; Micke P; Jönsson P; Brunnström H
Am J Clin Pathol; 2018 Oct; 150(6):533-544. PubMed ID: 30169783
[TBL] [Abstract][Full Text] [Related]
39. Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
Acta Cytol; 2010; 54(3):277-82. PubMed ID: 20518411
[TBL] [Abstract][Full Text] [Related]
40. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Bishop JA; Sharma R; Illei PB
Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
